Cytomegalovirus immune globulin intravenous (human) administration modulates immune response to alloantigens in sensitized renal transplant candidates.

MLA

Sivasal, K. S. R., et al. “Cytomegalovirus Immune Globulin Intravenous (Human) Administration Modulates Immune Response to Alloantigens in Sensitized Renal Transplant Candidates.” Clinical & Experimental Immunology, vol. 119, no. 3, Mar. 2000, p. 559. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=6103339&authtype=sso&custid=ns315887.

APA

Sivasal, K. S. R., Mohanakumar, T., Phelan, D., Martin, S., Anstey, M. E., & Brennan, D. C. (2000). Cytomegalovirus immune globulin intravenous (human) administration modulates immune response to alloantigens in sensitized renal transplant candidates. Clinical & Experimental Immunology, 119(3), 559.

Chicago

Sivasal, K.S.R., T. Mohanakumar, D. Phelan, S. Martin, M.E. Anstey, and D.C. Brennan. 2000. “Cytomegalovirus Immune Globulin Intravenous (Human) Administration Modulates Immune Response to Alloantigens in Sensitized Renal Transplant Candidates.” Clinical & Experimental Immunology 119 (3): 559. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=6103339&authtype=sso&custid=ns315887.